IP Library Granted Patent US 8,436,154
Granted Patent B2
US 8,436,154 · App. 13/063,933 · Granted May 7, 2013

Crystallizing method of erythromycin

Inventors: Xiaoping Ma (Dongguan, CN); Luning Song (Dongguan, CN)
Assignee: Sunshine Lake Pharma Co., Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,436,154
App. No.
13/063,933
Granted
May 7, 2013
Kind
B2
Abstract

The present invention provides an erythromycin crystallizing method, which comprises using dichloromethane containing solvent as a preparation solvent, and the dichloromethane solution of erythromycin received was gradiently cooled from high temperature down to low temperature, and thus making erythromycin crystallize. According to the method of the present invention, the content of erythromycin A is high, the content of erythromycin A in the erythromycin crystalline is more than 94.5% (HPLC detection method), the content of dichloromethane in the erythromycin crystalline is less than 600 ppm, the content of water in the erythromycin crystalline is less than 2.5%, the microbiological titre of the erythromycin crystalline is more than 940 μ/mg.

Claims (14)

1. A method for recrystallizing erythromycin, comprising the steps:

(1) first dissolving erythromycin or an erythromycin salt in dichloromethane or a solvent mixture comprising dichloromethane under alkaline condition to form an erythromycin solution, wherein the pH of the erythromycin solution is from 8.6 to 12;

(2) then cooling the erythromycin solution gradiently from 37° C. to −5° C. to form a suspension of erythromycin crystals, wherein a temperature is gradiently cooled from 37° C. to −5° C. at a cooling rate of 1° C. to 10° C. per hour for a recrystallization time period from 2 hours to 36 hours;

(3) then separating the erythromycin crystals from the suspension; and

(4) finally washing and drying the crystals.

2. The method of claim 1 , wherein the solvent mixture comprising dichloromethane further comprises a solvent selected from the group consisting of ethanol, acetone, ethyl acetate and butyl acetate; and the volume content of dichloromethane in the solvent mixture is from 60 to 100%.

3. The method of claim 1 , wherein the amount of erythromycin A in the erythromycin solution is from 4 to 20%.

4. The method of claim 1 , wherein the temperature of the erythromycin solution is kept at 23-28° C. for 1 to 10 hours during the gradient cooling.

5. The method of claim 1 , wherein an organic solvent or pure water is used for washing.

6. The method of claim 5 , wherein the organic solvent comprises more than 90% of dichloromethane and another organic solvent component, wherein the organic solvent component is an alcohol, ketone or ester.

7. The method of claim 2 , wherein the amount of erythromycin A in the erythromycin solution is from 4% to 20%.

8. The method of claim 2 , wherein an organic solvent or pure water is used for washing.

9. The method of claim 3 , wherein an organic solvent or pure water is used for washing.

10. The method of claim 4 , wherein an organic solvent or pure water is used for washing.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 8, 2020
From: NORTH & SOUTH BROTHER PHARMACY INVESTMENT COMPANY LIMITED
To: HEC PHARM CO. LTD.
Reel/Frame 054572/0629 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 25, 2019
From: SUNSHINE LAKE PHARMA CO., LTD.
To: NORTH & SOUTH BROTHER PHARMACY INVESTMENT COMPANY LIMITED
Reel/Frame 050832/0688 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 14, 2011
From: MA, XIAOPING; SONG, LUNING
To: SUNSHINE LAKE PHARMA CO., LTD
Reel/Frame 025952/0014 →
Priority Claims (1)
CN 2008 1 0225310 · Oct 29, 2008 · national
Continuity (1)
Related Publication 20110172402A1 · Jul 14, 2011